During the past decade, Penn State Hershey Bone and Joint Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Penn State Hershey Bone and Joint Institute" are "Deformity of Bone" (1 trials), "Limb Deformities Congenital" (1 trials), "Limb Deformities Nos (Acquired)" (1 trials), "Primary CNS Lymphoma" (1 trials) and "Refractory Primary Central Nervous System Lymphoma" (1 trials). Many other conditions were trialed in "Penn State Hershey Bone and Joint Institute" in a lesser frequency.

Most popular intervention types in "Penn State Hershey Bone and Joint Institute" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "DePuy Synthes MAXFRAMETM system" (1 trials) and "Tirabrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Penn State Hershey Bone and Joint Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Penn State Hershey Bone and Joint Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Penn State Hershey Bone and Joint Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Penn State Hershey Bone and Joint Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".